Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 7, 2010

View Archived Issues

LMV-601 is potently active against HSV and HPV in preclinical studies

Neutrophil elastase inhibitor AZD-9668 shows promise in COPD

Tuberculosis candidate PNU-100480 is well tolerated in healthy volunteers

Pfizer discloses new activators of glucokinase

FDA provides guidance to Celsion for ThermoDox NDA

SNPs in PIK3C2B gene correlate with risk of Parkinson's disease

B-27-PD enters phase I/II trial in chronic noninfectious uveitis

BioRelix and Merck & Co. subsidiary partner to identify antibacterial drug candidates

Artemether sublingual spray is safe and efficacious in children with severe malaria

Cosmo Pharma's CB-03-01 effective in proof-of-concept alopecia study

FDA orphan drug status for rozrolimupab in immune thrombocytopenia

FDA grants orphan drug status to Prolor's longer-acting human growth hormone

Viralytics advances phase I trial of coxsackievirus A21

Bionomics receives approval for two phase Ib trials of BNC-210 in France

Meda completes acquisition of Alaven

Daiichi Sankyo discovers new PPAR-gamma agonists

Starpharma and Lilly collaborate on dendrimer-drug conjugate development

UCB patents new inhibitors of PI3K isoforms

U.S. researchers claim new DNA topoisomerase 1 inhibitors

Flu vaccine LIQ-001 advances to clinic in phase I trial

Phase III trial of aripiprazole in schizophrenia meets efficacy criteria

Akebia Therapeutics presents data from phase IIa AKB-6548 trial

Japanese scientists disclose new diagnostics for Alzheimer's disease

Altravax receives NIH grants for research on vaccines for HIV-1

Johnson & Johnson to acquire all outstanding shares of Crucell

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...